Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.
Sushentsev N, Hamm G, Richings J, McLean MA, Menih IH, Ayyappan V, Mills IG, Warren AY, Gnanapragasam VJ, Barry ST, Goodwin RJA, Gallagher FA, Barrett T.
Sushentsev N, et al. Among authors: barrett t.
Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2312261120. doi: 10.1073/pnas.2312261120. Epub 2023 Nov 27.
Proc Natl Acad Sci U S A. 2023.
PMID: 38011568
Free PMC article.